Philip Tønnesen

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. doi request reprint Smoking cessation and COPD
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte Hospital, Niels Andersensvej 65, Hellerup, Copenhagen, Denmark
    Eur Respir Rev 22:37-43. 2013
  2. doi request reprint Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte Hospital, Copenhagen, Denmark
    Nicotine Tob Res 15:419-27. 2013
  3. pmc Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, DK 2900 Hellerup, Denmark
    Eur Respir J 40:548-54. 2012
  4. ncbi request reprint Smoking reduction for smokers not able or motivated to quit?
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, Hellerup, Denmark
    Respiration 69:475-8. 2002
  5. ncbi request reprint Which drug to be used in smoking cessation?
    Philip Tønnesen
    Department Pulmonary Medicine, Gentofte University Hospital, Copenhagen, Denmark
    Pol Arch Med Wewn 118:373-6. 2008
  6. ncbi request reprint [Varenicline--a new drug for smoking cessation]
    Philip Tønnesen
    Gentofte Hospital, Lungemedicinsk afdeling, Hellerup
    Ugeskr Laeger 169:4051-2. 2007
  7. ncbi request reprint Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
    P Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, 2900 Hellerup, Copenhagen, Denmark
    Eur Respir J 29:390-417. 2007
  8. ncbi request reprint Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support
    Philip Tønnesen
    Department of Pulmonary Medicine Y, Gentofte Hospital, Hellerup, Denmark
    Chest 130:334-42. 2006
  9. ncbi request reprint Essential communication skills in individual smoking cessation
    P Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, Hellerup, Copenhagen, Denmark
    Chron Respir Dis 1:221-7. 2004
  10. ncbi request reprint [Screening and prevention. Danish Society of Pulmonary Medicine]
    Philip Tønnesen
    Lungemedicinsk afdeling Y, Amtssygehuset i Gentofte, DK 2900 Hellerup
    Ugeskr Laeger 167:1395. 2005

Collaborators

Detail Information

Publications19

  1. doi request reprint Smoking cessation and COPD
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte Hospital, Niels Andersensvej 65, Hellerup, Copenhagen, Denmark
    Eur Respir Rev 22:37-43. 2013
    ..Smoking cessation is the most effective intervention in stopping the progression of COPD, as well as increasing survival and reducing morbidity. This is why smoking cessation should be the top priority in the treatment of COPD...
  2. doi request reprint Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte Hospital, Copenhagen, Denmark
    Nicotine Tob Res 15:419-27. 2013
    ..This study evaluated the effect of varenicline in combination with counseling to assist long-term nicotine replacement therapy (NRT) users to quit NRT...
  3. pmc Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, DK 2900 Hellerup, Denmark
    Eur Respir J 40:548-54. 2012
    ..The overall rate of treatment-related adverse events was 87.4% with active spray versus 71.4% with placebo spray. Nicotine mouth spray delivered significantly higher 6-, 24- and 52-week continuous abstinence rates than placebo...
  4. ncbi request reprint Smoking reduction for smokers not able or motivated to quit?
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, Hellerup, Denmark
    Respiration 69:475-8. 2002
    ..Further research is needed to evaluate the value of this concept. However, smoking cessation is still the ultimate goal...
  5. ncbi request reprint Which drug to be used in smoking cessation?
    Philip Tønnesen
    Department Pulmonary Medicine, Gentofte University Hospital, Copenhagen, Denmark
    Pol Arch Med Wewn 118:373-6. 2008
    ..With one of the 3 agents combined with follow-up visits with counselling, one can expect a 1-year quit rate around 20-25%...
  6. ncbi request reprint [Varenicline--a new drug for smoking cessation]
    Philip Tønnesen
    Gentofte Hospital, Lungemedicinsk afdeling, Hellerup
    Ugeskr Laeger 169:4051-2. 2007
    ..The adverse events were mild with transient nausea reported by less than one third of the subjects. Varenicline should be used for smoking cessation when nicotine replacement products have failed or are undesired...
  7. ncbi request reprint Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
    P Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, 2900 Hellerup, Copenhagen, Denmark
    Eur Respir J 29:390-417. 2007
    ..a budget should be established to enable implementation. Research is needed to establish optimum treatment strategies specifically for respiratory patients...
  8. ncbi request reprint Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support
    Philip Tønnesen
    Department of Pulmonary Medicine Y, Gentofte Hospital, Hellerup, Denmark
    Chest 130:334-42. 2006
    ..Few studies have examined the effect of nicotine replacement therapy (NRT) in COPD patients...
  9. ncbi request reprint Essential communication skills in individual smoking cessation
    P Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, Hellerup, Copenhagen, Denmark
    Chron Respir Dis 1:221-7. 2004
    ..The use of the five As to motivated smokers and the five Rs to smokers not ready to quit is recommended. Telephone and written material may supplement clinic visits in the follow-up period...
  10. ncbi request reprint [Screening and prevention. Danish Society of Pulmonary Medicine]
    Philip Tønnesen
    Lungemedicinsk afdeling Y, Amtssygehuset i Gentofte, DK 2900 Hellerup
    Ugeskr Laeger 167:1395. 2005
  11. ncbi request reprint A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation
    P Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, Gentofte, Denmark
    J Intern Med 254:184-92. 2003
    ..Bupropion sustained release (bupropion SR) has been shown to increase smoking cessation success rates in the US studies...
  12. ncbi request reprint Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme
    Haseem Ashraf
    Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark Department of Radiology, Akershus University Hospital, Lørenskog, Norway
    Thorax 69:574-9. 2014
    ..We present the final results of the effect of lung cancer screening with low-dose CT on the smoking habits of participants in a 5-year screening trial...
  13. ncbi request reprint Effects of smoking cessation and reduction in asthmatics
    Philip Tønnesen
    Department of Pulmonary Medicine Gentofte, University Hospital, Copenhagen, Denmark
    Nicotine Tob Res 7:139-48. 2005
    ....
  14. ncbi request reprint Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up
    Poul Wennike
    Department of Pulmonary Medicine, Gentofte University Hospital, Copenhagen, Denmark
    Addiction 98:1395-402. 2003
    ..To test the effect of nicotine gum and placebo in smokers not motivated or not able to quit smoking with regard to smoking reduction and smoking cessation...
  15. doi request reprint Smoking cessation with smokeless tobacco and group therapy: an open, randomized, controlled trial
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte Hospital, Niels Andersenvej 65, Hellerup, Denmark
    Nicotine Tob Res 10:1365-72. 2008
    ..A total of 25 subjects (17.5 %) were still using smokeless tobacco after 6 months. This trial demonstrated short-term efficacy of smokeless tobacco in combination with group support for smoking cessation but no long-term efficacy...
  16. doi request reprint Short-term effect of changes in smoking behaviour on emphysema quantification by CT
    Haseem Ashraf
    Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark
    Thorax 66:55-60. 2011
    ..The effect of smoking cessation and smoking relapse on lung density was studied using low-dose CT...
  17. doi request reprint Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST)
    H Ashraf
    Gentofte Hospital, Hellerup, Denmark
    Thorax 64:388-92. 2009
    ..The effect of low-dose CT screening for lung cancer on smoking habits has not been reported in large randomised controlled trials...
  18. doi request reprint CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
    Zaigham Saghir
    Department of Respiratory Medicine, Gentofte University Hospital, Niels Andersens Vej 65, Opgang 30A, 2900 Hellerup, Denmark
    Thorax 67:296-301. 2012
    ..The effects of low-dose CT screening on disease stage shift, mortality and overdiagnosis are unclear. Lung cancer findings and mortality rates are reported at the end of screening in the Danish Lung Cancer Screening Trial...
  19. doi request reprint Smoking cessation: How compelling is the evidence? A review
    Philip Tønnesen
    Department of Pulmonary Medicine, Gentofte University Hospital, Denmark
    Health Policy 91:S15-25. 2009
    ..To provide a short review of the evidence base supporting smoking cessation interventions, including behavioral therapy and pharmacological treatment options...